THE CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG RATHA AZHUTHA NIVARANI CHOORANAM IN PATIENTS HAVING HIGH BLOOD PRESSURE
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: I10-I16- Hypertensive diseases
- Registration Number
- CTRI/2019/02/017577
- Lead Sponsor
- GOVERNMENT SIDDHA MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
BLOOD PRESSURE LEVEL ABOVE 140/90mmHg AND BELOW 180/100mmHg
FATIGUE
HEADACHE
NAUSEA
GIDDINESS
SWEATING
OBESITY
Exclusion Criteria
BLOOD PRESSURE LEVEL ABOVE 180/100mmHg
HYPERTENSION IN PREGNANCY
ASSOCIATED OTHER SECONDARY DISEASES LIKE RENAL FAILURE CCF
OTHER CARDIAC PROBLEMS
CHRONIC DISEASES
HORMONAL DISORDERS
DIABETES MELLITUS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome is mainly assessed by decrease in BP to optimum levelTimepoint: Outcome is mainly assessed by decrease in BP to optimum level
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the active compounds in Ratha Azhutha Nivarani Chooranam and their molecular pathways in managing I10-I16 hypertensive diseases?
How does Ratha Azhutha Nivarani Chooranam compare to ACE inhibitors in treating stage 2 hypertension according to CTRI/2019/02/017577?
Which biomarkers predict response to Ratha Azhutha Nivarani Chooranam in patients with essential hypertension?
What are the safety profiles and adverse event management strategies for Ratha Azhutha Nivarani Chooranam in phase II hypertension trials?
Are there combination therapies involving Ratha Azhutha Nivarani Chooranam and calcium channel blockers for resistant hypertension?